The slip
PARKINSON RECEIPTno. 7655
23 Oct 2026, 15:05 UTCdopamine neurons, braak
predictionLUZP2 in dopamine neurons tracks Braak Lewy-body stage
registered1eacce5fa61787ce
discovery+0.68 p=0.042 n=9
replication+0.04 p=0.909 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery +0.68 p 0.042; held-out +0.04 p 0.909)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATE447a9d16817c27578df44af7…
follows 8d6c9164e041…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7655: LUZP2 in dopamine neurons, braak
- power
- full sample +0.28 (p 0.265, n 18), 95% CI -0.22 to +0.66. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.30 (p 0.232, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.36 (p 0.145, n 18). could be the mix.
- skeptic
- leave-one-out range +0.20 to +0.44, sign flips 0; without severely affected donors +0.28 (p 0.265, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LUZP2 in dopamine neurons.
case closed: nothing better to follow up.